1. Brieger k., Schiavone S., Miller Jr., Krause k. H. Reactive oxygen species: from health to disease. Swiss Medical Weekly, 2012, vol. 142, pp. 1-14. https://doi.org/10.4414/smw.2012.13659
2. Phaniendra A., Jestadi D. B., Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian Journal of Clinical Biochemistry, 2015, vol. 30, no. 1, pp. 11-26. https://doi.org/10.1007/s12291-014-0446-0
3. Huang J., Milton A., Arnold R. D., Huang H., Smith F., Panizzi J. R., Panizzi P. Methods for measuring myeloperoxidase activity toward assessing inhibitor efficacy in living systems. Journal of Leukocyte Biology, 2016, vol. 99, no. 4, pp. 541-548. https://doi.org/10.1189/jlb.3ru0615-256r
4. Tarpey M. M., Fridovich I. Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circulation Research, 2001, vol. 89, no. 3, pp. 224-236. https://doi.org/10.1161/hh1501.094365
5. Flemmig J., Remmler J., Zschaler J., Arnhold J. Detection of the halogenating activity of heme peroxidases in leukocytes by aminophenyl fluorescein. Free Radical Research, 2015, vol. 49, no. 6, pp. 768-776. https://doi.org/10.3109/1071 5762.2014.999676
6. Sokolov A. V., kostevich V. A., kozlov S. O., Donskyi I. S., Vlasova I. I., Rudenko A. O., Zakharova E. T., Vasilyev V. B., Panasenko O. M. kinetic method for assaying the halogenating activity of myeloperoxidase based on reaction of celestine blue B with taurine halogenamines. Free Radical Research, 2015, vol. 49, no. 6, pp. 777-789. https://doi.org/10.3109/10715762. 2015.1017478
7. Timoshenko A. V., Kayser K., Gabius H. J. Lectin-triggered superoxide/H2O2 and granule enzyme release from cells. Lectin Methods and Protocols. Humana Press, 1998, pp. 441-451. https://doi.org/10.1385/0-89603-396-1:441
8. Borges F., Fernandes E., Roleira F. Progress towards the discovery of xanthine oxidase inhibitors. Current Medicinal Chemistry, 2002, vol. 9, no. 2, pp. 195-217. https://doi.org/10.2174/0929867023371229
9. Malle E., Furtmüller P. G., Sattler W., Obinger C. Myeloperoxidase: a target for new drug development? British Journal of Pharmacology, 2007, vol. 152, no. 6, pp. 838-854. https://doi.org/10.1038/sj.bjp.0707358
10. Sokolov A. V., kostevich V. A., Varfolomeeva E. y., Grigorieva D. V., Gorudko I. V., kozlov S. O., kudryavtsev I. V., Mikhalchik E. V., Filatov M. V., Cherenkevich S. N., Panasenko O. M., Arnhold J., Vasilyev V. B. Capacity of ceruloplasmin to scavenge products of the respiratory burst of neutrophils is not altered by the products of reactions catalyzed by myeloperoxidase. Biochemistry and Cell Biology, 2018, vol. 96, no. 4, pp. 457-467. https://doi.org/10.1139/bcb-2017-0277
11. Winterbourn C. C., Metodiewa D. Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radical Biology & Medicine, 1999, vol. 27, no. 3-4, pp. 322-328. https://doi.org/10.1016/s0891-5849(99)00051-9